The corona vaccine that the pharmaceutical company AstraZeneca is working on together with the University of Oxford could be ready for use before Christmas.
Despite the fact that tests with the so-called Oxford vaccine were temporarily halted in September, the future looks bright again for the vaccine. AstraZeneca hopes to work with Oxford University to deliver the test results by the end of this year. That feeds the hope that we will have a corona vaccine before the end of 2020.
Professor Andrew Pollard, the person responsible for testing the vaccine, even mentions a “small chance that it will be there before Christmas.”
First vaccine for approval
According to Pollard, a vaccine would be an absolute game changer in the fight against the corona virus that has already killed more than 1.2 million people worldwide. If all goes to plan, the Oxford vaccine will be one of the first vaccines from major pharmaceutical companies to be submitted for approval.
Last week, the Financial Times announced that there are signs that the vaccine is leading to a robust immune response in the elderly. The elderly are said to produce neutralizing antibodies and T cells thanks to the drug. It is made from a weakened version of a cold virus that occurs in chimpanzees.
Pending the test results, production of the Oxford vaccine has already started. This production takes place at ten locations around the world, including one in Belgium: the Hainaut site of the French pharmaceutical company Novasep.
The European Commission has now concluded a purchase agreement with AstraZeneca.